Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $25.3 million.

  • Surgery Partners' Net Income towards Common Stockholders rose 29531.25% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year decrease of 7797.73%. This contributed to the annual value of $12.5 million for FY2024, which is 20504.2% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Net Income towards Common Stockholders is $25.3 million, which was up 29531.25% from $44.9 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Net Income towards Common Stockholders peaked at $57.7 million during Q2 2023, and registered a low of -$46.6 million during Q4 2024.
  • Its 5-year average for Net Income towards Common Stockholders is $4.3 million, with a median of $1.2 million in 2023.
  • Per our database at Business Quant, Surgery Partners' Net Income towards Common Stockholders tumbled by 2330000.0% in 2022 and then surged by 192500.0% in 2024.
  • Quarter analysis of 5 years shows Surgery Partners' Net Income towards Common Stockholders stood at -$100000.0 in 2021, then tumbled by 23300.0% to -$23.4 million in 2022, then skyrocketed by 299.57% to $46.7 million in 2023, then crashed by 199.79% to -$46.6 million in 2024, then surged by 154.29% to $25.3 million in 2025.
  • Its last three reported values are $25.3 million in Q3 2025, $44.9 million for Q2 2025, and -$300000.0 during Q1 2025.